Rapport Therapeutics, Inc. Common Stock
USD41.91
+1.52 (+3.76%)
CEO
Abraham N. Ceesay
IPO Date
2024-06-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$40.40
Prev. Close
$40.39
Day Low
$40.05
Day High
$43.76
52W Low
$11.05
52W High
$43.75
Market Cap
$1.53B
Volume
0.36M
| 15,200 |
| $35.21 |
| 10 Jun 2026 | PAUL STEVEN M | director | A-Award | Acquired | 15,200 | $35.21 |
| 10 Jun 2026 | Silva Paul M | director | A-Award | Acquired | 15,200 | $35.21 |
| 10 Jun 2026 | HEALY JAMES | director | A-Award | Acquired | 15,200 | $35.21 |
| 10 Jun 2026 | Huber Reid M | director | A-Award | Acquired | 15,200 | $35.21 |
| 10 Jun 2026 | Young Wendy B. | director | A-Award | Acquired | 15,200 | $35.21 |
| 10 Jun 2026 | Sanchez Ramiro | director | A-Award | Acquired | 15,200 | $35.21 |
| 28 May 2026 | Third Rock Ventures V, L.P. | 10 percent owner | S-Sale | Disposed | 18,572 | $40.05 |
| 13 May 2026 | Third Rock Ventures V, L.P. | 10 percent owner | S-Sale | Disposed | 133,618 | $40.24 |